This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Robak, E Articles by Robak, T Search for Related Content PubMed PubMed Citation Articles by Robak, E Articles by Robak, T Social Bookmarking                         What's this?

Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosus

Department of Dermatology and Venereology, Medical University of Lodz, Lodz, Poland robaktad{at}csk.umed.lodz.pl

M Kierstan

Department of Dermatology and Venereology, Medical University of Lodz, Lodz, Poland

B Cebula

Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland

A Krawczynska

Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland

A Sysa-Jedrzejowska

Department of Dermatology and Venereology, Medical University of Lodz, Lodz, Poland

A Wierzbowska

Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland

P Smolewski

Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland

T Robak

Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland robaktad{at}csk.umed.lodz.pl

The aim of our study was to assess absolute counts of different subpopulations of circulating endothelial cells (CEC) in patients with active and inactive systemic lupus erythematosus (SLE). We have also investigated a potential correlation of CEC numbers with serum levels of angiogenic proteins as well as with clinical and laboratory symptoms of the disease. For the first time in SLE, CEC were enumerated directly, by the ‘single platform’ method. Resting (rCEC), activated (aCEC) and progenitor (pCEC) endothelial cells were identified in patients with SLE and healthy volunteers using four-colour flow cytometry. Serum concentrations of angiogenic proteins (vascular endothelial growth factor, placental growth factor (PIGF), soluble vascular cell adhesion molecule and endoglin) were evaluated by ELISA. The SLE activity was scored according to the Systemic Lupus Activity Measure system. We found that total CEC number in patients with SLE was significantly higher (median 14.2/µL) than in the control group (median 3.3/µL) (P < 0.0001). Absolute counts of aCEC, rCEC and pCEC (medians 4.9/µL, 6.8/µL and 2.3/µL, respectively) were also higher in patients with SLE than in healthy persons (medians 0.9/µL, 1.6/µL and 0.1/µL, respectively), with P < 0.0001 for all comparisons. There was no correlation between CEC or their subpopulations and SLE activity. Strong positive correlations were found between CEC, rCEC and pCEC numbers and serum levels of PIGF. Moreover, aCEC, rCEC and pCEC counts were significantly higher in SLE patients with leukopenia. In conclusion, our results show that absolute CEC counts and angiogenic proteins levels are elevated in patients with SLE as compared with healthy controls. These data may suggest that angiogenic process is involved in the pathogenesis of this disease.

Key Words: endoglin • endothelial cell • PIGF • SLE • sVCAM-1 • VEGF

Lupus, Vol. 18, No. 4, 332-341 (2009)
DOI: 10.1177/0961203308097572


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?